Brief: Kalvista Pharmaceuticals Says Potential FDA Approval And Launch Of Sebetralstat In First Half of 2025
11/07/2024 11:38
July 11 (Reuters) - Kalvista Pharmaceuticals Inc
KALV.O :
* KALVISTA PHARMACEUTICALS INC -POTENTIAL FDA APPROVAL AND
LAUNCH
OF SEBETRALSTAT IN FIRST HALF 2025
Source text for Eikon: ID:nBwBpLWma
Further company coverage: KALV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalvista Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 08:36 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Seagate, GE Healthcare, Bloom Energy